[Federal Register Volume 83, Number 145 (Friday, July 27, 2018)]
[Notices]
[Pages 35644-35645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16102]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Health Statistics (NCHS), ICD-10 Coordination 
and Maintenance (C&M) Committee Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The CDC, National Center for Health Statistics (NCHS), 
Classifications and Public Health Data Standards Staff, announces the 
following meeting of the ICD-10 Coordination and Maintenance (C&M) 
Committee meeting. This meeting is open to the public, limited only by 
the space available. The meeting room accommodates approximately 240 
people. We will be broadcasting the meeting live via Webcast at hhtp://
www.cms.gov/live/.

DATES: The meeting will be held on September 11, 2018, 9:00 a.m. to 
5:00 p.m. EDT and September 12, 2018, 9:00 a.m. to 5:00 p.m. EDT.

ADDRESSES: Centers for Medicare and Medicaid Services (CMS) Auditorium, 
7500 Security Boulevard, Baltimore, Maryland 21244.

FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Program Specialist, 
CDC, 3311 Toledo Rd., Hyattsville, MD 20782 telephone (301) 458-4454; 
email address [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is 
a public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Tenth Revision, Clinical 
Modification and ICD-10 Procedure Coding System.
    Matters To Be Considered: The agenda will include discussions on 
ICD-10-PCS Topics:

Intraoperative Fluorescence Vascular Angiography for Lymphatic Mapping 
in Cervical and Uterine Cancers
Insertion of Intramedullary Nail Limb Lengthening System
Cell Suspension Autografting--REPEAT
Subcutaneous Implantable Defibrillator System

[[Page 35645]]

Administration of erdafitinib
Administration of esketamine hydrochloride nasal spray, for intranasal 
use
Administration of ERLEADATM (apalutamide), for oral use

Addenda and Key Updates

ICD-10-CM Topics
Deep Vein Thrombosis
Dravet Syndrome
Latent Tuberculosis Infection
Pressure ulcer of mucosal membrane by site
ICD-10-CM Addendum

    Agenda items are subject to change as priorities dictate.
    Security Considerations: Due to increased security requirements, 
CMS has instituted stringent procedures for entrance into the building 
by non-government employees.
    Attendees will need to present valid government-issued picture 
identification, and sign-in at the security desk upon entering the 
building.
    Attendees who wish to attend the September 11-12, 2018, ICD-10-CM 
C&M meeting must submit their name and organization by September 3, 
2018, for inclusion on the visitor list. This visitor list will be 
maintained at the front desk of the CMS building and used by the guards 
to admit visitors to the meeting.
    Participants who attended previous Coordination and Maintenance 
meetings will no longer be automatically added to the visitor list. You 
must request inclusion of your name prior to each meeting you wish 
attend.
    Please register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/.
    Please contact Mady Hue (410-786-4510) or [email protected] 
for questions about the registration process.

    Note: CMS and NCHS no longer provide paper copies of handouts 
for the meeting. Electronic copies of all meeting materials will be 
posted on the CMS and NCHS websites prior to the meeting at http://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm.

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Dia Taylor,
Acting Chief Operating Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2018-16102 Filed 7-26-18; 8:45 am]
BILLING CODE 4160-18-P